115 related articles for article (PubMed ID: 8105129)
1. Peptide histidine methionine in cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Yasuda M; Minamitani N; Maeda K
Jpn J Psychiatry Neurol; 1993 Mar; 47(1):85-90. PubMed ID: 8105129
[TBL] [Abstract][Full Text] [Related]
2. Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin.
Yasuda M; Maeda K; Kakigi T; Minamitani N; Kawaguchi T; Tanaka C
Neuropeptides; 1995 Dec; 29(6):325-30. PubMed ID: 8837959
[TBL] [Abstract][Full Text] [Related]
3. Peptide histidine methionine and vasoactive intestinal peptide levels in human cerebrospinal fluid: age-related changes and absence of a correlation with serum prolactin.
Yasuda M; Minamitani N; Maeda K; Chihara K; Fujita K; Kobayashi I
Regul Pept; 1993 Jul; 46(3):565-73. PubMed ID: 8210516
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the course of senile dementia of the Alzheimer type using cerebrospinal fluid levels of acetylcholinesterase and somatostatin.
Urakami K; Adachi Y; Awaki E; Takahashi K
Acta Neurol Scand; 1989 Sep; 80(3):232-7. PubMed ID: 2572139
[TBL] [Abstract][Full Text] [Related]
6. Peptide histidine methionine may be a prolactin-releasing hormone in humans.
Sasaki A; Sato S; Shinkawa O; Go M; Otsuka T; Sugawara A; Shimizu Y; Murakami O; Hanew K; Andoh N
J Clin Endocrinol Metab; 1988 Jun; 66(6):1202-7. PubMed ID: 3131380
[TBL] [Abstract][Full Text] [Related]
7. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
[TBL] [Abstract][Full Text] [Related]
8. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
[TBL] [Abstract][Full Text] [Related]
10. Decreased level of beta-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Kaiya H; Tanaka T; Takeuchi K; Morita K; Adachi S; Shirakawa H; Ueki H; Namba M
Life Sci; 1983 Sep; 33(11):1039-43. PubMed ID: 6310293
[TBL] [Abstract][Full Text] [Related]
11. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.
Alafuzoff I; Adolfsson R; Bucht G; Winblad B
J Neurol Sci; 1983; 60(3):465-72. PubMed ID: 6631444
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.
Strittmatter M; Hamann GF; Grauer MT; Cramer H; Schimrigk K
Dement Geriatr Cogn Disord; 1997; 8(1):34-42. PubMed ID: 8997550
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.
Atack JR; Beal MF; May C; Kaye JA; Mazurek MF; Kay AD; Rapoport SI
Arch Neurol; 1988 Mar; 45(3):269-74. PubMed ID: 2893600
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid corticotropin-releasing hormone and ACTH, and peripherally circulating choline-containing phospholipid in senile dementia.
Suemaru S; Suemaru K; Hashimoto K; Ogasa T; Hirasawa R; Makino S; Kageyama J
Life Sci; 1993; 53(9):697-706. PubMed ID: 8394971
[TBL] [Abstract][Full Text] [Related]
15. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid somatostatin in delirium.
Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
[TBL] [Abstract][Full Text] [Related]
17. Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men.
Regland B; Abrahamsson L; Blennow K; Gottfries CG; Wallin A
Acta Neurol Scand; 1992 Apr; 85(4):276-81. PubMed ID: 1585799
[TBL] [Abstract][Full Text] [Related]
18. Amino acid concentrations in cerebrospinal fluid in presenile and senile dementia of Alzheimer type and multi-infarct dementia.
Degrell I; Hellsing K; Nagy E; Niklasson F
Arch Gerontol Geriatr; 1989; 9(2):123-35. PubMed ID: 2686573
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin cerebrospinal fluid levels in dementia.
Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
